Company Filing History:
Years Active: 2011-2012
Title: Sara Orgad: Innovator in Cancer Research
Introduction
Sara Orgad is a prominent inventor based in Gedera, Israel. She has made significant contributions to the field of cancer research, particularly through her innovative work on synthetic antibodies. With a total of 2 patents, her research focuses on the development of targeted therapies for cancer treatment.
Latest Patents
Sara Orgad's latest patents include groundbreaking work on human synthetic single-chain antibodies directed against the common epitope of mutant P53. These patents detail isolated polypeptides, isolated polynucleotides, and expression vectors that encode these antibodies. The inventions also encompass viral display vehicles that specifically bind to an exposed epitope shared by mutant P53 protein, while not affecting the wild type. Furthermore, the patents provide methods for inducing apoptosis, treating cancer, and diagnosing P53-related cancers using the isolated polypeptides uncovered by her research.
Career Highlights
Sara Orgad is affiliated with Tel Aviv University, where she continues her research and development in the field of cancer therapies. Her work has garnered attention for its potential to revolutionize treatment options for patients with P53-related cancers.
Collaborations
Sara has collaborated with notable colleagues, including Beka Solomon and Itai Benhar, to advance her research initiatives. Their combined expertise contributes to the innovative approaches being developed in the realm of cancer treatment.
Conclusion
Sara Orgad's contributions to cancer research through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work promises to pave the way for new therapeutic strategies in the fight against cancer.